Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
SuppreMol
company
About
SuppreMol is a biotechnology company developing treatment of autoimmune diseases leading to the cure of such disorders.
- 10001 - max
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- €15.50M
- Industries
- Biotechnology,Health Care,Medical Device
- Founded date
- Jan 1, 2002
- Number Of Employee
- 10001 - max
- Operating Status
- Active
SuppreMol is a privately held biotechnology company that pioneers a novel approach for the treatment of autoimmune diseases which could lead to the cure of these disorders instead of merely treating their symptoms.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
€40.70M $5.15M
SuppreMol has raised a total of
€40.70M $5.15M
in funding over 2 rounds. Their latest funding was raised on
May 21, 2013 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 21, 2013 | Series D | €9.50M | 1 | — | — | Detail |
| Dec 17, 2010 | Series C | €15.50M | 2 | — | — | Detail |
| Jul 15, 2008 | Series B | €15.70M | 1 | — | — | Detail |
| May 24, 2006 | Series A | $5.15M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
SuppreMol is funded by 2 investors.
FCP Biotech Holding
and Bayern Kapital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series D |
Bayern Kapital
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
